Free Trial

IMAC (BACK) Competitors

IMAC logo
$0.06 0.00 (0.00%)
As of 07/25/2025 01:28 PM Eastern

BACK vs. BTTX, UPHL, ACONW, AONC, DHACW, LFMDP, OTRKP, PIIIW, TALKW, and TOIIW

Should you be buying IMAC stock or one of its competitors? The main competitors of IMAC include Better Therapeutics (BTTX), UpHealth (UPHL), Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), and Oncology Institute (TOIIW). These companies are all part of the "healthcare" industry.

IMAC vs. Its Competitors

IMAC (NASDAQ:BACK) and Better Therapeutics (NASDAQ:BTTX) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, profitability, risk, institutional ownership, dividends, media sentiment, valuation and earnings.

5.8% of IMAC shares are owned by institutional investors. Comparatively, 34.0% of Better Therapeutics shares are owned by institutional investors. 12.3% of IMAC shares are owned by insiders. Comparatively, 51.4% of Better Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

IMAC has a beta of 2.18, indicating that its stock price is 118% more volatile than the S&P 500. Comparatively, Better Therapeutics has a beta of 0.96, indicating that its stock price is 4% less volatile than the S&P 500.

In the previous week, IMAC had 3 more articles in the media than Better Therapeutics. MarketBeat recorded 3 mentions for IMAC and 0 mentions for Better Therapeutics. Better Therapeutics' average media sentiment score of 0.00 beat IMAC's score of -0.06 indicating that Better Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
IMAC Neutral
Better Therapeutics Neutral

IMAC has higher revenue and earnings than Better Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IMAC$72.05K1.73-$9.42MN/AN/A
Better TherapeuticsN/AN/A-$39.76MN/AN/A

Company Net Margins Return on Equity Return on Assets
IMACN/A N/A -325.44%
Better Therapeutics N/A N/A N/A

Summary

IMAC and Better Therapeutics tied by winning 4 of the 8 factors compared between the two stocks.

Get IMAC News Delivered to You Automatically

Sign up to receive the latest news and ratings for BACK and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BACK vs. The Competition

MetricIMACSpecialty outpatient clinics IndustryMedical SectorNASDAQ Exchange
Market Cap$124K$124K$5.70B$9.50B
Dividend YieldN/AN/A4.60%4.01%
P/E RatioN/AN/A28.1020.06
Price / Sales1.731.73429.3889.33
Price / CashN/AN/A36.2258.56
Price / Book-0.09N/A8.665.87
Net Income-$9.42M-$9.42M$3.25B$258.55M
7 Day PerformanceN/AN/A4.22%3.73%
1 Month PerformanceN/AN/A10.51%11.75%
1 Year PerformanceN/AN/A34.40%18.02%

IMAC Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BACK
IMAC
N/A$0.06
flat
N/A-96.5%$124K$72.05K0.00180
BTTX
Better Therapeutics
N/A$0.00
flat
N/A-66.7%$5KN/A0.0040
UPHL
UpHealth
N/A$0.00
flat
N/A-100.0%$4K$130M0.001,750
ACONW
Aclarion
N/A$0.02
+4.1%
N/A-9.7%$0.00$54.60K0.007Positive News
Gap Up
AONC
American Oncology Network
N/A$10.00
+1.0%
N/A+381.6%$0.00$1.34B0.001,520News Coverage
Gap Down
DHACW
Digital Health Acquisition
N/A$0.04
flat
N/A-63.7%$0.00N/A0.00N/AGap Up
LFMDP
LifeMD
N/A$23.15
-0.3%
N/A+9.7%$0.00$234.01M0.00230Positive News
OTRKP
Ontrak
N/A$0.26
+13.3%
N/A+41.9%$0.00$10.84M0.00250Gap Down
PIIIW
P3 Health Partners
N/A$0.01
+20.5%
N/A-65.7%$0.00$1.49B0.00500Gap Down
TALKW
Talkspace
N/A$0.08
+15.1%
N/A-20.8%$0.00$194.36M0.00500Positive News
Gap Down
TOIIW
Oncology Institute
N/A$0.09
-1.0%
N/AN/A$0.00$403.15M0.00660Positive News
Gap Up

Related Companies and Tools


This page (NASDAQ:BACK) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners